Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 3
Submit an article Journal homepage
738
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

The critical factors for COVID-19 vaccination uptake are perceived ‎vaccine effectiveness and the desire to protect others

Danna Valinskya The Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1136-9084View further author information
ORCID Icon,
Anthony D. Heymanna The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;b Meuhedet Health Services, Tel Aviv, IsraelView further author information
,
Dov Albukrekb Meuhedet Health Services, Tel Aviv, IsraelView further author information
,
Judith Tsamirb Meuhedet Health Services, Tel Aviv, IsraelView further author information
&
Galia Zacaya The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;b Meuhedet Health Services, Tel Aviv, IsraelView further author information
Article: 2265170 | Received 07 Jun 2023, Accepted 27 Sep 2023, Published online: 17 Oct 2023

References

  • Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–8. doi:10.1016/S0140-6736(21)00947-8.
  • Leshem E, Wilder-Smith A. COVID-19 vaccine impact in Israel and a way out of the pandemic. Lancet. 2021;397(10287):1783–5. doi:10.1016/S0140-6736(21)01018-7.
  • Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, Mizrahi B, Alroy-Preis S, Ash N, Milo R, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393–400. doi:10.1056/NEJMoa2114255.
  • Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, Reis BY, Balicer RD. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398(10316):2093–100. doi:10.1016/S0140-6736(21)02249-2.
  • COVID-19 data dashboard [Internet]. Israel Ministry of Health. [ accessed 2021 Mar 19]. https://datadashboard.health.gov.il/COVID-19/general.
  • Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Heal. 2021;9(August). doi:10.3389/fpubh.2021.698111.
  • Monto AS. The future of SARS-CoV-2 vaccination — lessons from influenza. N Engl J Med. 2021;385(20):1825–7. doi:10.1056/NEJMp2113403.
  • MOH. Influenza | Ministry of health [Internet]. Ministry of Health; 2009. https://www.moh.gov.sg/content/moh_web/home/diseases_and_conditions/i/influenza.html.
  • Shasha D, Valinsky L, Hershkowitz Sikron F, Glatman-Freedman A, Mandelboim M, Toledano A, Paran Y, Ben-Ami R, Goldman D. Quadrivalent versus trivalent influenza vaccine: clinical outcomes in two influenza seasons, historical cohort study. Clin Microbiol Infect [Internet]. 2020;26(1):101–6. doi:10.1016/j.cmi.2019.05.003.
  • Schwartz AW, Clarfield AM, Doucette JT, Valinsky L, Karpati T, Landrigan PJ, Sternberg SA. Disparities in pneumococcal and influenza immunization among older adults in Israel: a cross-sectional analysis of socio-demographic barriers to vaccination. Prev Med. 2013;56(5):337–40. doi:10.1016/j.ypmed.2013.01.019.
  • MacDonald NE SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4. doi:10.1016/j.vaccine.2015.04.036.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines [Internet]. 2021;9(2):160. doi:10.3390/vaccines9020160.
  • Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021;397(10277):875–7. doi:10.1016/S0140-6736(21)00448-7.
  • Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005-2016. PLoS One. 2017;12:2005–16. doi:10.1371/journal.pone.0170550.
  • Luyten J, Bruyneel L, van Hoek AJ. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Vaccine [Internet]. 2019;37(18):2494–501. doi:10.1016/j.vaccine.2019.03.041.
  • Graupensperger S, Abdallah DA, Lee CM. Social norms and vaccine uptake: college students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine. Vaccine [Internet]. 2021;39(15):2060–7. doi:10.1016/j.vaccine.2021.03.018.
  • Malik AA, McFadden SAM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine [Internet]. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495.
  • Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: a longitudinal study. PLoS One [Internet]. 2021;16(4 April):1–12. doi:10.1371/journal.pone.0250123.
  • Gallant AJ, Brown Nicholls LA, Rasmussen S, Cogan N, Young D, Williams L. Changes in attitudes to vaccination as a result of the COVID-19 pandemic: a longitudinal study of older adults in the UK. PLoS One [Internet]. 2021;16(12):1–11. doi:http://dx.doi.org/10.1371/journal.pone.0261844.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.